AU4594200A - Pharmaceutical combination of neurokinin receptor antagonist and proton pump inhibitor - Google Patents

Pharmaceutical combination of neurokinin receptor antagonist and proton pump inhibitor

Info

Publication number
AU4594200A
AU4594200A AU45942/00A AU4594200A AU4594200A AU 4594200 A AU4594200 A AU 4594200A AU 45942/00 A AU45942/00 A AU 45942/00A AU 4594200 A AU4594200 A AU 4594200A AU 4594200 A AU4594200 A AU 4594200A
Authority
AU
Australia
Prior art keywords
receptor antagonist
proton pump
pharmaceutical combination
pump inhibitor
neurokinin receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45942/00A
Inventor
Barrington John Albert Furr
William Leroy Rumsey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU4594200A publication Critical patent/AU4594200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
AU45942/00A 1999-05-13 2000-05-09 Pharmaceutical combination of neurokinin receptor antagonist and proton pump inhibitor Abandoned AU4594200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9911017.3A GB9911017D0 (en) 1999-05-13 1999-05-13 Pharmaceutical compositions
GB9911017 1999-05-13
PCT/GB2000/001775 WO2000069438A1 (en) 1999-05-13 2000-05-09 Pharmaceutical combination of neurokinin receptor antagonist and proton pump inhibitor

Publications (1)

Publication Number Publication Date
AU4594200A true AU4594200A (en) 2000-12-05

Family

ID=10853315

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45942/00A Abandoned AU4594200A (en) 1999-05-13 2000-05-09 Pharmaceutical combination of neurokinin receptor antagonist and proton pump inhibitor

Country Status (3)

Country Link
AU (1) AU4594200A (en)
GB (1) GB9911017D0 (en)
WO (1) WO2000069438A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
SE0004827D0 (en) 2000-12-22 2000-12-22 Astrazeneca Ab Therapeutic compounds
PL373287A1 (en) * 2002-05-07 2005-08-22 Altana Pharma Ag New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders
JP2005526848A (en) * 2002-05-07 2005-09-08 アルタナ　ファルマ　アクチエンゲゼルシャフト Combinations for treating airway diseases
CA2493618A1 (en) 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2005074931A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Pharmaceutical combinations comprising (s) -pantoprazole
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN171746B (en) * 1989-11-02 1992-12-26 Mcneil Ppc Inc
WO1993012817A1 (en) * 1991-12-20 1993-07-08 Warner-Lambert Company Therapeutic combinations useful in the treatment of gastroesophageal reflux disease
US6013680A (en) * 1997-10-21 2000-01-11 Amano Pharmaceutical Co., Ltd. Digestive enzyme-containing medicament
WO1999059612A1 (en) * 1998-05-15 1999-11-25 Aphton Corporation Method for the treatment of gastroesophageal reflux disease
JP2000026311A (en) * 1998-07-02 2000-01-25 Amano Pharmaceut Co Ltd Composition of gastric emptying ability accelerator
GB9924141D0 (en) * 1998-10-30 1999-12-15 Zeneca Ltd Treatment of gastric asthma
GB9826941D0 (en) * 1998-12-09 1999-02-03 Zeneca Pharmaceuticals Compounds

Also Published As

Publication number Publication date
WO2000069438A1 (en) 2000-11-23
GB9911017D0 (en) 1999-07-14

Similar Documents

Publication Publication Date Title
AU1585601A (en) Transdermal administration of huperzine
HUP0203323A3 (en) Tyrosine kinase inhibitors and pharmaceutical compositions containing them
HUP0202682A3 (en) Tyrosine kinase inhibitors, pharmaceutical compositions containing them and their use
AU2002213357A1 (en) Variant igg3 rituxan r and therapeutic use thereof
ATE380814T1 (en) KINASE INHIBITORS AS MEDICINAL PRODUCTS
ZA200306488B (en) Benzamides and related inhibitors of factor Xa.
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
AU4300701A (en) Methods and compositions for administration of therapeutic reagents
HUP0200325A2 (en) Pharmaceutical composition containing proton pump inhibitors
AU2003229084A1 (en) Methods and formulations for the delivery of pharmacologically active agents
AU5326100A (en) Pharmaceutical compositions and methods for use
AU7079700A (en) Improved stable formulations of ace inhibitors, and methods for preparation thereof
AU3885900A (en) Inhibitors of the egf-receptor tyrosine kinase and their use
AU2001252406A1 (en) Pharmaceutical compositions comprising proton pump inhibitors and gastrin/cholecystokinin receptor ligands
AU4594200A (en) Pharmaceutical combination of neurokinin receptor antagonist and proton pump inhibitor
HK1047893A1 (en) Pharmaceutical combinations comprising a p2t receptor antagonist and melagatran
AU2371400A (en) Vitronectin receptor antagonist pharmaceuticals
AU5901900A (en) Indole and indazole urea-peptoids as thrombin receptor antagonists
AU1189201A (en) Therapeutic compositions including protein kinase c inhibitors
AU5460800A (en) Pharmaceutical transdermal compositions
AU2001230898A1 (en) Formulations and methods for administration of pharmacologically or biologicallyactive compounds
AU2456701A (en) Pharmaceutical and veterinary uses of endothelin antagonists
IL127518A (en) Substituted heterocyclic benzocycloalkenes, their preparation and pharmaceutical compositions having an analgesic effect
AU1068101A (en) Transdermal administration of reboxetine
AUPQ570100A0 (en) Beta-alanine derivatives and their use as receptor antagonists

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase